Tobacco

Advocate for public policies proven to reduce tobacco use and save lives. These include well-funded tobacco prevention and cessation programs, prohibitions on flavored tobacco products, and effective regulation of tobacco products and marketing.

P.L. 111-31 - Family Smoking Prevention and Tobacco Control and Federal Retirement Reform Act - implementation of provisions relating to regulation of tobacco; 81 FR 289783 (May 10, 2016) - implementation of Food and Drug Administration final rule deeming certain tobacco products, including electronic cigarettes, as subject to FDA regulation; H.R. 4121 & S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 - Title VII - Food and Drug Administration - Section 733 - provisions related to federal regulation of tobacco.

Discussions related to implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act. Discussions related to the importance of tobacco harm reduction and the availability of FDA-authorized smoke-free products. Discussions related to educating adult smokers about smoke-free products, the continuum of risk, and misconceptions about nicotine. Discussions related to efforts to address smoking rates in certain populations where there has not been a meaningful decline. Discussions related to enforcement of illicit tobacco products, including importation and distribution of counterfeit products. Discussions related to user fees for tobacco product and nicotine products. Discussions related to efforts to prevent underage access to tobacco products. Discussions related to reforms of the Food and Drug Administrations Center for Tobacco Products. Discussions related to PMTA and MRTPA submissions and FDA authorization of scientifically-substantiated products. Discussions related to the misperception of nicotine in the context of tobacco policy and public health.

General Tobacco Related Activities General Tobacco Taxation General Tariff Policy Deemed Product Warning Labels Premarket Review of Tobacco Products Substantial Equivalence of Tobacco Products Deeming Rule Food & Drug Administration Oversight, Accountability, and Transparency Health and Economic Impacts of Premium Cigars The Traditional Cigar Manufacturing and Small Business Jobs Preservation Act US Foreign Policy on Issues in the Caribbean Basin FDA Proposed Rules Prohibiting Menthol Cigarettes and Flavored Cigars Proposed Rule on Tobacco Manufacturing Practices Credit Card Competition Act Private Sector communications and payment processing restrictions on the sale of tobacco products Section 301 Investigations

Lobbying Report: January 1st - March 31st, 2026 (Action Fund)  Federal (under tobacco issue code) Legislation: H.R. 5342/S. 2354, FY 26 Commerce, Justice, Science, and Related Agencies Appropriations Act H.R. 6845/S. 3569, Strengthening Task Force Operations to Prevent Illicit Vaping Act (S.T.O.P. Illicit Vaping Act) H.R. 5304/S. 2587, FY 26 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act H.R. 6844, Tracking, Reporting, and Accountability for Compliance in Enforcement Act (Tobacco TRACE Act) H.R. 4779, FY 26 National Security, Department of State, and Related Programs Appropriations Act FY 26 Senate State, Foreign Operations, and Related Programs Appropriations Act FY 27 Commerce, Justice, Science, and Related Agencies Appropriations Act FY 27 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act FY 27 National Security, Department of State, and Related Programs Appropriations Act / State, Foreign Operations, and Related Programs Appropriations Act FY 27 Agriculture, Rural Development, and Related Agencies Appropriations Act S. 4257 Resources to Prevent Youth Vaping Act H.R. 7567 Farm, Food, and National Security Act of 2026 H.R. 2111, to amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations. Issues: CDC tobacco prevention and cessation programs and funding Congressional Caucus to End Youth Vaping FDA authority over tobacco products Federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes CDC Chronic disease prevention programs FDA enforcement against unauthorized tobacco products FDA review of flavored e-cigarettes FDA oversight of nicotine pouches Tobacco Harm Reduction Caucus Agencies Visited: Food and Drug Administration US House of Representatives US Senate

Issues related to the removal of duty drawback repeal provisions (H.R.1 - One Big Beautiful Bill Act). Issues related to harm reduction policies with regards to tobacco consumption (no specific legislation). Supported efforts by Members of Congress to urge the Administration to take strong enforcement actions against illicit Chinese vaping products flooding the United States market (no specific legislation).

General Tobacco Issues; Menthol, Nicotine, and Vaping Issues.

-Discussions related to tobacco harm reduction -Discussions related to the enforcement of illicit tobacco products, including the importation of counterfeit products -Discussions related to user fees for tobacco and electronic nicotine delivery system products -Discussions related to efforts to prevent youth access to tobacco products